Prostate Volume And PSA Density Calculator

Key Takeaways

• Prostate volume and PSA density are important factors in diagnosing and monitoring prostate conditions, especially prostate cancer.
• Prostate volume is a measure of the size of the prostate, while PSA density assesses the risk of prostate cancer by dividing the PSA level by the prostate volume.
• Calculating prostate volume and PSA density can provide valuable insights into the effectiveness of treatment strategies and guide clinical decision-making.

Introduction

Prostate volume and Prostate-Specific Antigen (PSA) density are two critical factors in diagnosing and monitoring prostate conditions, particularly prostate cancer. This article will delve into these concepts, providing a comprehensive understanding of their significance in the field of radiology.

Understanding Prostate Volume

The prostate is a small gland that forms part of the male reproductive system. It’s located below the bladder and surrounds the urethra, which is the tube that carries urine from the bladder out through the penis. The size of the prostate can vary greatly among men. Typically, a healthy prostate measures 3 cm high by 4 cm wide by 2 cm deep, roughly the size of a walnut.

Prostate volume is a measure of the size of the prostate. It’s usually measured in cubic centimeters (cc) or milliliters (ml), with 1 cc being equal to 1 ml. The volume of the prostate can be calculated using transrectal ultrasound (TRUS), which provides images of the prostate that can be used to measure its dimensions.

The size of the prostate can have significant implications for a man’s health. An enlarged prostate, a condition known as benign prostatic hyperplasia (BPH), can cause uncomfortable urinary symptoms, such as frequent urination, difficulty starting and stopping urination, and weak urine flow.

Understanding PSA (Prostate-Specific Antigen)

Prostate-Specific Antigen (PSA) is a protein produced by both normal and malignant cells of the prostate gland. It’s present in small quantities in the serum of men with healthy prostates but is often elevated in the presence of prostate cancer or other prostate disorders.

A PSA test measures the level of PSA in a man’s blood and is one of the primary methods used to screen for prostate cancer. The test involves drawing blood from a vein in your arm and sending it to a lab for analysis.

The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood. According to most medical professionals, a PSA level under 4 ng/mL is considered normal. However, some doctors recommend further testing if a man’s PSA level is above 2.5 or 3 ng/mL.

The Concept of PSA Density

PSA density is a calculation used to assess the risk of prostate cancer. It’s determined by dividing the PSA level by the volume of the prostate. The rationale behind this calculation is that a larger prostate will naturally produce more PSA, so men with larger prostates may have higher PSA levels even in the absence of cancer.

PSA density can help differentiate between BPH and prostate cancer, as men with BPH tend to have a lower PSA density compared to those with prostate cancer. A PSA density of 0.15 or higher is often considered suspicious for prostate cancer.

Calculating Prostate Volume and PSA Density

The volume of the prostate is typically calculated using measurements taken from a transrectal ultrasound (TRUS). The formula used is:

Prostate Volume = Length x Width x Height x π/6

Once the volume of the prostate has been determined, the PSA density can be calculated by dividing the serum PSA level by the volume of the prostate. The formula used is:

PSA Density = Serum PSA Level / Prostate Volume

For example, if a man has a serum PSA level of 4 ng/mL and a prostate volume of 30 cc, his PSA density would be 0.13 ng/mL/cc.

Interpreting the Results

Interpreting the results of these calculations requires clinical expertise. While a high PSA level or high PSA density can be indicative of prostate cancer, they are not definitive diagnostic tools. Other factors, such as age, race, family history, and results from digital rectal exams (DREs), must also be considered.

In general, a PSA level above 4 ng/mL or a PSA density above 0.15 ng/mL/cc may warrant further investigation, such as a biopsy. However, these thresholds are not absolute, and decisions should always be made in consultation with a healthcare provider.

Clinical Applications

The calculations of prostate volume and PSA density have significant clinical applications. They are primarily used in the diagnosis and monitoring of prostate cancer. A high PSA level or a high PSA density can be indicative of prostate cancer, prompting further investigation such as a biopsy.

Moreover, these calculations are also useful in monitoring the progress of patients who have been diagnosed with prostate conditions. Changes in the prostate volume or PSA density over time can provide valuable insights into the effectiveness of treatment strategies.

Case Studies

To illustrate the practical application of these calculations, let’s consider a few hypothetical case studies:

1. Case Study 1: A 60-year-old man presents with urinary symptoms. His serum PSA level is 4 ng/mL, and his prostate volume is 30 cc, giving a PSA density of 0.13 ng/mL/cc. Given his age and the fact that his PSA density is below the threshold of suspicion (0.15 ng/mL/cc), his symptoms may be due to BPH rather than prostate cancer.
2. Case Study 2: A 50-year-old man has a serum PSA level of 6 ng/mL and a prostate volume of 20 cc. His PSA density is 0.3 ng/mL/cc, which is above the threshold of suspicion. Further investigation, such as a biopsy, may be warranted in this case.

What is the utility of this Prostate Volume Calculator?

You can calculate the volume of the prostate gland using this calculator using values acquired on MRI or Ultrasound. This will give an estimate of the size of the prostate gland. The normal prostate gland is approximately 25-30cc in volume.

Prostate-specific antigen (PSA) is a tumor marker for prostate cancer. PSA density can be used to prognosticate prostate malignancies. Patients with low PSA density can undergo active surveillance while those with higher values may need intervention. As stated by PSA-density might inform biopsy decisions, and spare some men from the morbidity associated with a prostate biopsy and diagnosis of low-grade prostate cancer.

What formulas are used for calculating prostate volume, and what are the cut-off values?

Prostate Volume = (Anteroposterior (AP) length x Transverse (TR) length x Craniocaudal Length )*0.523

Note that the PIRADS 2.1 ACR white paper recommends that the AP and TR length should be measured on the sagittal plane as shown in the image above.

A gland volume of more than 30cc is considered prostatomegaly.

A rough grading system for prostatomegaly is :
30-50cc: Mild Prostatomegaly
50-80cc : Moderate Prostatomegaly
>80cc: Marked Prostatomegaly.

What formulas are used for calculating PSA density, and what are the cut-off values?

PSA density = PSA value/Prostate Volume

Although the cut-off values vary, most papers suggest a cut-off value of 0.15-0.20 above which there is a high chance of the patient having clinically significant prostate cancer.

A recent study states the following optimal cut-off values of PSA density to diagnose clinically significant prostate cancer :

• 0.10 ng/ml2 in biopsy naïve patients i.e. patients who have not had a prostate biopsy
• 0.15 ng/ml2 in patients with a previous negative biopsy.

Sasaki et. al suggested in their study: “To avoid unnecessary biopsies, the PSA density cutoff value of 0.18 would be recommendable for determining a prostate biopsy for Japanese males with a serum total PSA level of 4.1-10.0 ng/ml.”

What are the common causes of prostatomegaly (prostate gland enlargement)?

• Benign prostatic hyperplasia (BPH) – Most common cause of prostatomegaly in elderly men. This causes urinary symptoms due to indentation on the posterior bladder wall.
• Prostate cancer
• Prostatitis
• Prostatic abscess

Should we use PSA or PSA density to prognosticate prostate cancers?

PSA density is preferred over PSA alone as the latter can be elevated in inflammation and in a larger gland.

As per a study by Bruno et. al: “At multivariable analysis adjusting for age, biopsy history, DRE and prostate volume, PSA density emerged as a strong predictor of clinically significant prostate cancer (csPCA) but was not associated with prostatic inflammation. The optimal cutoffs of PSA density to diagnose csPCa and rule out the presence of prostatic inflammation in patients with an elevated PSA (>4 ng/ml) were 0.10 ng/ml2 in biopsy naïve patients and 0.15 ng/ml2 in patients with a previous negative biopsy. PSA density rather than PSA should be used to evaluate patients at risk of prostate cancer who may need additional testing or prostate biopsy. This readily available parameter can potentially identify men who do not have PCa but have an elevated PSA secondary to benign conditions.”

In another study, Sasaki et.al conclude: “PSA density was significantly more accurate than other variables in predicting PCa. To avoid unnecessary biopsies, the PSA density cutoff value of 0.18 would be recommendable for determining a biopsy for Japanese males with a serum total PSA level of 4.1-10.0 ng/ml.”

What is clinically significant prostate cancer (csPCA)?

Clinically significant cancer is usually defined as a Gleason Score of more than or equal to 7 on biopsy.

Limitations and Considerations

While the calculations of prostate volume and PSA density are valuable tools in the field of radiology, they do have their limitations. For instance, both BPH and prostatitis can cause an increase in PSA levels, which can lead to a false-positive result for cancer.

It’s also important to note that these calculations should not be used in isolation. They should be considered as part of a comprehensive diagnostic approach that includes other factors such as age, race, family history, and results from digital rectal exams (DREs).

Conclusion

Prostate volume and PSA density are crucial parameters in diagnosing and monitoring prostate conditions. While they are not definitive diagnostic tools on their own, they provide valuable information that can guide clinical decision-making when used in conjunction with other diagnostic factors.

Check out other radiology useful calculators:

Frequently Asked Questions Regarding Prostate Volume and PSA Density Calculations

Disclaimer: The author makes no claims of the accuracy of the information contained herein; this information is for educational purposes only and is not a substitute for clinical judgment.

References:

• Bruno, Salvatore, et al. “PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study.” Frontiers in Oncology, vol. 11, 2021, https://doi.org/10.3389/fonc.2021.693684. Accessed 17 Dec. 2022.
• Sasaki R, Habuchi T, Sato K, et al. The clinical utility of measuring total PSA, PSA density, gamma-seminoprotein and gamma-seminoprotein/total PSA in prostate cancer prediction. Jpn J Clin Oncol. 2000;30(8):337-342. doi:10.1093/jjco/hyd089.
• Nordström T, Akre O, Aly M, Grönberg H, Eklund M. Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer Prostatic Dis. 2018;21(1):57-63. doi:10.1038/s41391-017-0024-7
• Lim J, Bhoo-Pathy N, Sothilingam S, et al. Ethnicity is an independent determinant of age-specific PSA
• Flevel: findings from a multiethnic Asian setting. PLoS One. 2014;9(8):e104917. Published 2014 Aug 11. doi:10.1371/journal.pone.0104917